Your browser doesn't support javascript.
loading
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Patel, Anushka; Cass, Alan; Peiris, David; Usherwood, Tim; Brown, Alex; Jan, Stephen; Neal, Bruce; Hillis, Graham S; Rafter, Natasha; Tonkin, Andrew; Webster, Ruth; Billot, Laurent; Bompoint, Severine; Burch, Carol; Burke, Hugh; Hayman, Noel; Molanus, Barbara; Reid, Christopher M; Shiel, Louise; Togni, Samantha; Rodgers, Anthony.
Afiliação
  • Patel A; The George Institute for Global Health, University of Sydney, Australia apatel@georgeinstitute.org.
  • Cass A; The George Institute for Global Health, University of Sydney, Australia Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • Peiris D; The George Institute for Global Health, University of Sydney, Australia.
  • Usherwood T; Department of General Practice, Sydney Medical School (Westmead), The University of Sydney, Australia.
  • Brown A; Baker IDI Centre for Indigenous Vascular and Diabetes Research, Alice Springs, Australia South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Jan S; The George Institute for Global Health, University of Sydney, Australia.
  • Neal B; The George Institute for Global Health, University of Sydney, Australia.
  • Hillis GS; The George Institute for Global Health, University of Sydney, Australia.
  • Rafter N; National Institute for Health Innovation, School of Population Health, University of Auckland, New Zealand.
  • Tonkin A; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
  • Webster R; The George Institute for Global Health, University of Sydney, Australia.
  • Billot L; The George Institute for Global Health, University of Sydney, Australia.
  • Bompoint S; The George Institute for Global Health, University of Sydney, Australia.
  • Burch C; The George Institute for Global Health, University of Sydney, Australia.
  • Burke H; Maari Ma Aboriginal Corporation, Broken Hill, Australia.
  • Hayman N; Inala Indigenous Health Service, Australia.
  • Molanus B; Baker IDI Centre for Indigenous Vascular and Diabetes Research, Alice Springs, Australia.
  • Reid CM; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Shiel L; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Togni S; Baker IDI Centre for Indigenous Vascular and Diabetes Research, Alice Springs, Australia.
  • Rodgers A; The George Institute for Global Health, University of Sydney, Australia.
Eur J Prev Cardiol ; 22(7): 920-30, 2015 Jul.
Article em En | MEDLINE | ID: mdl-24676715
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prevenção Primária / Inibidores da Agregação Plaquetária / Doenças Cardiovasculares / Medicamentos Genéricos / Inibidores de Hidroximetilglutaril-CoA Redutases / Hiperlipidemias / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies País como assunto: Oceania Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prevenção Primária / Inibidores da Agregação Plaquetária / Doenças Cardiovasculares / Medicamentos Genéricos / Inibidores de Hidroximetilglutaril-CoA Redutases / Hiperlipidemias / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies País como assunto: Oceania Idioma: En Ano de publicação: 2015 Tipo de documento: Article